A Plausible Answer Is Not a Correct One
The FDA has authorized more than 1,400 AI-enabled medical devices. Not one of them is a large language model. That is not caution. It is the design brief.
Read More
Intelligence briefings at the intersection of defense, aerospace, and emerging technology — quantum intelligence, cybersecurity, insurtech, space and satellite risk, maritime supply chain, sustainment economics, and compliance.
The FDA has authorized more than 1,400 AI-enabled medical devices. Not one of them is a large language model. That is not caution. It is the design brief.
The ransomware never reached Colonial’s control systems. They shut down 5,500 miles of pipeline anyway — because nobody could prove, in the first hour, that it hadn’t.
Exploration is the only industry that routinely spends six figures to learn it was wrong. A dry hole is not a failure of execution. It is the base case.
A fund learns a portfolio company is in trouble at the board meeting, from a deck the company prepared. By then its role has narrowed from prevention to triage.
The signal was in the data eleven days before the incident. It always is. The only question is whether anyone was going to see it before the incident did.
A standard commercial general liability form excludes the exposure you actually have. The gaps don’t announce themselves — they wait for a claim to find them.
The acquisition price is the number everyone argues about. Operating and support is the number that decides whether the program is affordable.
A closed chokepoint is a known problem. A half-open one is a moving target — and the recovery itself is the next disruption.
Your risk profile is a photograph taken at renewal and filed until the next one. The operation doesn’t hold still in between.
EO 14412 set the dates. The Department of War says nearly every deployed military asset is affected. What the 2030 and 2031 deadlines actually require.
